TRI

Valcare Medical Announces Enrollment of First Two Patients in AMEND™ TS EU Pilot Study

TAMPA, Fla., May 14, 2024 /PRNewswire/ -- Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, announces the successful…

Valcare Medical Valcare Medical

Replicate Bioscience Presents Positive Data from Phase 1 Trial and Preclinical Data with Novel Self-Replicating RNA at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Positive data from Phase 1 trial of RBI-4000 vaccine achieve WHO-established surrogate of protection across all dose cohorts Vector improvements…

Replicate Bioscience Replicate Bioscience

TAR-210 results show 90% recurrence-free survival and 90% complete response in patients with high-risk and intermediate-risk non-muscle-invasive bladder cancer, respectively

Updated results reinforce the potential of TAR-210 to transform treatment of non–muscle-invasive bladder cancer with fibroblast growth factor receptor (FGFR)…

Johnson & Johnson Johnson & Johnson
- Advertisement -
Ad imageAd image
Latest TRI News